Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1995-07-18
1997-11-11
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242021, 4242291, 4352351, 536 2372, C12N 700, C12N 701, C12N 1538, A61K 39295
Patent
active
056860765
ABSTRACT:
The present invention relates to a gD-negative Bovine Herpesvirus mutant, that has the property of direct cell-to-cell transmission. The invention also relates to a DNA-fragment capable of conferring this property to Bovine Herpesviruses, not possessing the direct cell-to-cell transmission capability. Also, the invention relates to a vaccine based on this mutant, and a method for the protection of animals against Bovine Herpesvirus.
REFERENCES:
F. Fehler et al., Journal of Virology, 66:2:831-839, Fet. 1992.
S.K. Tikoo et al., Journal of Virology, 64:10:5132-5142, Oct. 1990.
Mettenlater et al 1994 J. Gen. Virol vol. 75:1723-1733.
Ligas et al 1988 J. Virol 62(5) 1486-1494.
Akzo Nobel N.V.
Blackstone William M.
Gormley Mary E.
Mosher Mary E.
Salimi Ali R.
LandOfFree
gD-negative bovine herpesvirus mutant, capable of direct cell-to does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with gD-negative bovine herpesvirus mutant, capable of direct cell-to, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and gD-negative bovine herpesvirus mutant, capable of direct cell-to will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1226635